← Evidence map

ReviewPharmaceuticals (Basel, Switzerland)2016

Targeting TRPM2 in ROS-Coupled Diseases.

Shinichiro Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27618067